NCT06132204View on ClinicalTrials.gov

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

March 13, 2024

Study Completion Date

March 13, 2024

Conditions

Type 2 Diabetes

Interventions

DRUG

HRS-7535 Tablets

Trial Locations (1)

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06132204 - Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects | Biotech Hunter | Biotech Hunter